BioSpace News Archive

Business

Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2021

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the second quarter 2021.

August 5, 2021
·
20 min read
Business

Acceleron Reports Second Quarter 2021 Financial Results

Acceleron Pharma Inc., a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, reported financial results for the second quarter ended June 30, 2021.

August 5, 2021
·
14 min read
Humanized Mouse Model Market Report | How has COVID-19 affected the market?

TMR Research speaks on the core issues and characteristics of the global humanized mouse model market, along with its nuances and opportunities of growth over the coming years, in “Humanized Mouse Model Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.”

August 5, 2021
·
5 min read
Diabetic Foot Ulcers and Pressure Ulcers Market: Diabetic Foot Ulcers to Remain Leading Segment Based on Treatment Type

The global diabetic foot ulcers and pressure ulcers market depicts the presence of few market players, says Transparency Market Research on the basis of a recently published report.

August 5, 2021
·
4 min read
Biotech Beach

Inmagene and Kissei Enter into an Exclusive License Agreement for Fostamatinib in China

Inmagene Biopharmaceuticals and Kissei Pharmaceutical Co., Ltd. announced that they have entered into an exclusive license agreement for the development and commercialization of fostamatinib in mainland China, Hong Kong and Macau.

August 5, 2021
·
3 min read
Business

Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced that it will host a conference call on August 12, 2021 at 4 pm CET following the announcement of results for the second quarter of 2021.

August 5, 2021
·
3 min read
Biotech Beach

Praxis Bioresearch Awarded $2.9 Million Fast-Track SBIR Grant for Development of Novel Therapy for Apathy in Alzheimer’s Disease

Praxis is proud to announce to be the recipient of a Fast-Track SBIR award to develop treatment for apathy in Alzheimer’s Disease.

August 5, 2021
·
5 min read
Business

Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

Amarin Corporation plc, announced financial results for the second quarter and six months ended June 30, 2021 and provided an update on company operations.

August 5, 2021
·
33 min read
Business

BD Announces Third Fiscal Quarter Results; Strong Base Growth Drives Better Performance In Quarter And Higher Guidance For Fiscal 2021

BD, a leading global medical technology company, reported quarterly revenues of $4.9 billion for the third fiscal quarter ended June 30, 2021.

August 5, 2021
·
18 min read
Drug Development

Phase 3 Trial of Libtayo® (cemiplimab-rwlc) Combined with Chemotherapy Stopped Early Due to Significant Improvement in Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer

Regeneron Pharmaceuticals, Inc. and Sanofi announced the Phase 3 trial of PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early after meeting its overall survival primary endpoint in patients with advanced non-small cell lung cancer.

August 5, 2021
·
21 min read